GlassScriptPhysician profile
Andrew M Freeman
NPI 1033167697
$11,431.84
in general payments reported to CMS, 2019-2025
16 companies · $2,700 in 2025
The $2,700 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $70.81 · 2021: $244 · 2022: $165 · 2023: $37.65 · 2024: $8,215 · 2025: $2,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,715.00 |
| Food and Beverage | $237.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $10,841.08 | 2024-2025 | |
| Novo Nordisk INC | $164.71 | 2021-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $73.36 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $69.36 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $56.19 | 2021 | |
| Supernus Pharmaceuticals, INC. | $49.17 | 2021 | |
| Daiichi Sankyo INC. | $33.74 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $26.05 | 2021-2022 | |
| Exact Sciences Corporation | $23.26 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $22.78 | 2024 | Eterna |
| Bayer Healthcare Pharmaceuticals INC. | $12.48 | 2022 | |
| Amgen INC. | $12.41 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.37 | 2019 | |
| Allergan, INC. | $12.29 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.06 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.